Assessment of Quality of Life and Outcomes in Patients Treated With Stereotactic Body Radiation Therapy (SBRT) for Primary Renal Cell Carcinoma (RCC) - AQuOS-RCC
Stereotactic body radiation therapy (SBRT) is an emerging radiation therapy technique that precisely
delivers high doses of radiation to tumours. It has been investigated as definitive
treatment for an increasing variety of primary tumours including lung, liver, prostate, and
now renal cell carcinoma (RCC). The principal aims of this study are to prospectively assess
quality of life (QoL) and oncologic outcomes in non-surgical patients who receive SBRT for
the treatment of RCC.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society